{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:32:00Z","timestamp":1793723520770,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA053094"],"award-info":[{"award-number":["UG3DA053094"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS130882"],"award-info":[{"award-number":["R01NS130882"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.coph.2025.102528","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T20:56:56Z","timestamp":1746737816000},"page":"102528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Delta opioid receptors: Overlooked outlier or the next big thing"],"prefix":"10.1016","volume":"83","author":[{"given":"Amal","family":"El Daibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Rysztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Jutkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-2976","authenticated-orcid":false,"given":"Amynah A.","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2025.102528_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.coph.2025.102528_bib2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2025.102528_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00429-014-0717-9","article-title":"A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks","volume":"220","author":"Erbs","year":"2015","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.coph.2025.102528_bib4","article-title":"Hypoxic\/ischemic inflammation, MicroRNAs and delta-opioid receptors: hypoxia\/ischemia-sensitive versus-insensitive organs","volume":"14","author":"Chen","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/jpet.122.001182","article-title":"Delta opioid receptor-mediated antidepressant-like effects of diprenorphine in mice","volume":"384","author":"Olson","year":"2023","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2025.102528_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070873","article-title":"Opportunities and challenges for in silico drug discovery at delta opioid receptors","volume":"15","author":"Meqbil","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.coph.2025.102528_bib7","doi-asserted-by":"crossref","first-page":"G66","DOI":"10.1152\/ajpgi.00297.2021","article-title":"Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders","volume":"322","author":"DiCello","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2025.102528_bib8","series-title":"Migraine pain management: current pharmacological and non-pharmacological options","first-page":"167","article-title":"Delta opioid receptor system","author":"El Daibani","year":"2025"},{"key":"10.1016\/j.coph.2025.102528_bib9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00213-015-4195-4","article-title":"A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression","volume":"233","author":"Richards","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2025.102528_bib10","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1097\/j.pain.0000000000002235","article-title":"Delta opioid receptor regulation of CGRP dynamics in the trigeminal complex","volume":"162","author":"Moye","year":"2021","journal-title":"Pain"},{"key":"10.1016\/j.coph.2025.102528_sref11","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/bph.17424","article-title":"Activation of delta-opioid receptors blocks allodynia in a model of headache induced by PACAP","volume":"182","author":"Mangutov","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2025.102528_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2018.12.017","article-title":"Delta opioid receptor agonists are effective for multiple types of headache disorders","volume":"148","author":"Moye","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2025.102528_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/head.14517","article-title":"Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptors","volume":"63","author":"Mei","year":"2023","journal-title":"Headache"},{"key":"10.1016\/j.coph.2025.102528_bib14","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1093\/brain\/awac139","article-title":"Dual enkephalinase inhibitor PL37 as a potential novel treatment of migraine: evidence from a rat model","volume":"145","author":"Descheemaeker","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.coph.2025.102528_bib15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa2314577","article-title":"A monoclonal antibody to PACAP for migraine prevention","volume":"391","author":"Ashina","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2025.102528_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1113\/JP284003","article-title":"Morphine-induced mechanical hypersensitivity in mice requires delta receptors, beta-arrestin2, and c-Src activity","volume":"601","author":"Singleton","year":"2023","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2025.102528_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbi.2024.09.031","article-title":"Upregulation of delta opioid receptor by meningeal interleukin-10 prevents relapsing pain","volume":"123","author":"Inyang","year":"2025","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.coph.2025.102528_bib18","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1523\/JNEUROSCI.1182-22.2022","article-title":"HDAC6 inhibition reverses cisplatin-induced mechanical hypersensitivity via tonic delta opioid receptor signaling","volume":"42","author":"Zhang","year":"2022","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147298","article-title":"The \u03bc-\u03b4 opioid heteromer masks latent pain sensitization in neuropathic and inflammatory pain in male and female mice","volume":"1756","author":"Inyang","year":"2021","journal-title":"Brain Res"},{"key":"10.1016\/j.coph.2025.102528_sref20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.adq6531","article-title":"Meningeal regulatory T cells inhibit nociception in female mice","volume":"388","author":"Midavaine","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.coph.2025.102528_sref21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/s41586-024-07816-z","article-title":"Neural circuit basis of placebo pain relief","volume":"632","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.coph.2025.102528_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109526","article-title":"Receptor expression and signaling properties in the brain, and structural ligand motifs that contribute to delta opioid receptor agonist-induced seizures","volume":"232","author":"Blaine","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2025.102528_sref23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/jpet.119.262717","article-title":"Pharmacological properties of delta-opioid receptor-mediated behaviors: agonist efficacy and receptor reserve","volume":"374","author":"Dripps","year":"2020","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2025.102528_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69746","article-title":"Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons","volume":"10","author":"He","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.coph.2025.102528_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147297","article-title":"A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice","volume":"1757","author":"Sakamoto","year":"2021","journal-title":"Brain Res"},{"key":"10.1016\/j.coph.2025.102528_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1124\/jpet.119.258640","article-title":"A novel G protein-biased agonist at the delta opioid receptor with analgesic efficacy in models of chronic pain","volume":"372","author":"Conibear","year":"2020","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2025.102528_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s40263-020-00738-0","article-title":"A Phase I, randomized, single-blind, placebo-controlled, single ascending dose study of the safety, tolerability, and pharmacokinetics of subcutaneous and oral TRV250, a G protein-selective delta receptor agonist, in healthy subjects","volume":"34","author":"Fossler","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.coph.2025.102528_sref28","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1038\/s41467-025-57734-5","article-title":"Structure-guided design of partial agonists at an opioid receptor","volume":"16","author":"Varga","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2025.102528_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tibs.2014.03.002","article-title":"Allosteric sodium in class A GPCR signaling","volume":"39","author":"Katritch","year":"2014","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.coph.2025.102528_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/science.1219218","article-title":"Structural basis for allosteric regulation of GPCRs by sodium ions","volume":"337","author":"Liu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.coph.2025.102528_bib31","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1038\/s41467-024-52601-1","article-title":"Cryo-EM structure of small-molecule agonist bound delta opioid receptor-G(i) complex enables discovery of biased compound","volume":"15","author":"Cheng","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2025.102528_bib32","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/acschembio.4c00231","article-title":"Identification of cytisine derivatives as agonists of the human delta opioid receptor by supercomputer-based virtual drug screening and transcriptomics","volume":"19","author":"Damiescu","year":"2024","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.coph.2025.102528_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci12070860","article-title":"Delta opioid receptors and enkephalinergic signaling within locus coeruleus promote stress resilience","volume":"12","author":"Tkaczynski","year":"2022","journal-title":"Brain Sci"},{"key":"10.1016\/j.coph.2025.102528_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jnr.24680","article-title":"Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain","volume":"100","author":"Cahill","year":"2022","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.coph.2025.102528_bib35","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1523\/JNEUROSCI.23-12-04888.2003","article-title":"Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice","volume":"23","author":"Morinville","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/ALN.0000000000004880","article-title":"Nerve growth factor\/tyrosine kinase A receptor pathway enhances analgesia in an experimental mouse model of bone cancer pain by increasing membrane levels of delta-opioid receptors","volume":"140","author":"Kan","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.coph.2025.102528_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105668","article-title":"Functional diversification of cell signaling by GPCR localization","volume":"300","author":"Klauer","year":"2024","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2025.102528_bib38","doi-asserted-by":"crossref","first-page":"15281","DOI":"10.1073\/pnas.2000500117","article-title":"Endosomal signaling of delta opioid receptors is an endogenous mechanism and therapeutic target for relief from inflammatory pain","volume":"117","author":"Jimenez-Vargas","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2025.102528_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.919773","article-title":"Opioid receptor-mediated regulation of neurotransmission in the brain","volume":"15","author":"Reeves","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2022.932546","article-title":"The role of enkephalinergic systems in substance use disorders","volume":"16","author":"Rysztak","year":"2022","journal-title":"Front Syst Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib41","first-page":"1","article-title":"Amygdala intercalated cells form an evolutionarily conserved system orchestrating brain networks","author":"Aksoy-Aksel","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41593-023-01518-x","article-title":"Updating the striatal-pallidal wiring diagram","volume":"27","author":"Fang","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib43","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/s41593-024-01697-1","article-title":"Unlocking opioid neuropeptide dynamics with genetically encoded biosensors","volume":"27","author":"Dong","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2025.102528_bib44","doi-asserted-by":"crossref","first-page":"13358","DOI":"10.1002\/anie.202101262","article-title":"Designing a single protein-chain reporter for opioid detection at cellular resolution","volume":"60","author":"Kroning","year":"2021","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.coph.2025.102528_bib45","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/j.pain.0000000000002925","article-title":"Early-life adversity increases morphine tolerance and persistent inflammatory hypersensitivity through upregulation of delta opioid receptors in mice","volume":"164","author":"Singleton","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.coph.2025.102528_sref46","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1038\/s41467-024-51004-6","article-title":"Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function","volume":"15","author":"Meulebrouck","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2025.102528_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237236","article-title":"Identification of a novel delta opioid receptor agonist chemotype with potential negative allosteric modulator capabilities","volume":"26","author":"Meqbil","year":"2021","journal-title":"Molecules"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489225000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:26:01Z","timestamp":1774517161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489225000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":47,"alternative-id":["S1471489225000244"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2025.102528","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delta opioid receptors: Overlooked outlier or the next big thing","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2025.102528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102528"}}